ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Not detected |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAP1 | ArfGAP with dual PH domains 1 | | | | | | Mixed |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
ADCK4 | AarF domain containing kinase 4 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ADD1 | Adducin 1 (alpha) | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
ADD3 | Adducin 3 (gamma) | Cytoskeleton related proteins
| | | | | Expressed in all |
ADGB | Androglobin | Enzymes
| | | | | Group enriched |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins
| | | | | Tissue enriched |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins
| | | | | Expressed in all |
ADH7 | Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | Enzymes
| | | | | Tissue enriched |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADNP | Activity-dependent neuroprotector homeobox | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ADO | 2-aminoethanethiol (cysteamine) dioxygenase | Enzymes
| | | | | Expressed in all |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
ADPRHL2 | ADP-ribosylhydrolase like 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
ADRM1 | Adhesion regulating molecule 1 | | | | | | Expressed in all |
ADSL | Adenylosuccinate lyase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ADSS | Adenylosuccinate synthase | Enzymes Plasma proteins
| | | | | Expressed in all |
AFAP1 | Actin filament associated protein 1 | | | | | | Mixed |
AFAP1L1 | Actin filament associated protein 1-like 1 | | | | | | Mixed |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AGA | Aspartylglucosaminidase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGAP3 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 | | | | | | Expressed in all |
AGFG2 | ArfGAP with FG repeats 2 | | | | | | Tissue enriched |
AGK | Acylglycerol kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AGO2 | Argonaute RISC catalytic component 2 | Plasma proteins
| | | | | Expressed in all |
AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPS | Alkylglycerone phosphate synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGR2 | Anterior gradient 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AGXT | Alanine-glyoxylate aminotransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Tissue enriched |
AHCTF1 | AT hook containing transcription factor 1 | | | | | | Expressed in all |
AHDC1 | AT hook, DNA binding motif, containing 1 | | | | | | Expressed in all |